Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00022978
DRKS00022978
Completed
Not Applicable

Quantitative Sensory Testing (QST) as a tool to assess and quantify thoracic pain in patients with chronic interstitial lung disease (ILD)

niversitätsmedizin Essen, Ruhrlandklinik0 sites79 target enrollmentAugust 31, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsJ84.9R07.4Interstitial pulmonary disease, unspecifiedChest pain, unspecified

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
J84.9
Sponsor
niversitätsmedizin Essen, Ruhrlandklinik
Enrollment
79
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 31, 2020
End Date
November 12, 2019
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsmedizin Essen, Ruhrlandklinik

Eligibility Criteria

Inclusion Criteria

  • •Outpatients and inpatients of the Ruhrlandklinik;
  • •Interstitial lung disease diagnosed according to ATS/ERS criteria 2002 or 2013 (3\): IPF, NSIP, COP, EAA, DIP, RBILD, PAP

Exclusion Criteria

  • •Incompletely documented history or
  • •unclassifiable ILD

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Quantitative Sensory Testing (QST) to establish a somatosensory phenotype in pulmonary surgery - Identification of risk factors and a sensitive predictor in QST testing for chronic post-thoracotomy pain and its neuropathic component.G89.22: Chronic post-thoracotomy pain
DRKS00015102niversitätsmedizin Essen, Ruhrlandklinik182
Recruiting
Not Applicable
Quantitative Sensory Testing (QST) in The Diagnostic & Therapeutic Process of patients with Painful Cervical Facet ArthropathyChronic Neck Pain1002321310005944
NL-OMON34812niversitair Medisch Centrum Sint Radboud92
Completed
Not Applicable
Quantitative sensory testing (QST) protocol.
NL-OMON34703PRA International EDS400
Active, not recruiting
Phase 1
Evaluation of sensory testing to measure the effects of tetrodotoxipainTherapeutic area: Diseases [C] - Nervous System Diseases [C10]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
CTIS2022-500318-24-00eiden University Medical Center25
Active, not recruiting
Phase 2
Tetrodotoxin and quantitative sensory testing in healthy volunteersPainSigns and Symptoms
ISRCTN78737401eiden University Medical Center25